Previous 10 | Next 10 |
Healthcare veteran brings 30+ years of medtech experience to Axo g en, Inc. Board of Directors ALACHUA, Fla., Sept. 30, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or d...
ALACHUA, Fla., Sept. 25, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced that Karen Zaderej, chairman, CEO, and president, will present at the JM...
ALACHUA, Fla., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that it will participate in the 75 th Annual Meeting of the American Socie...
AxoGen (NASDAQ: AXGN ) shares spike +23% after hours following the announcement of higher revenue guidance for third quarter. More news on: AxoGen, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
ALACHUA, Fla., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced that Karen Zaderej, chairman, CEO, and president will present at the Cant...
The following slide deck was published by AxoGen, Inc. in conjunction with their 2020 Q2 earnings Read more ...
Image source: The Motley Fool. AxoGen Inc (NASDAQ: AXGN) Q2 2020 Earnings Call Aug 5, 2020 , 4:30 p.m. ET Operator Continue reading
AxoGen, Inc. (AXGN) Q2 2020 Earnings Conference Call August 05, 2020 4:30 PM ET Company Participants Pete Mariani – Chief Financial Officer Karen Zaderej – Chairman, Chief Executive Officer and President Conference Call Participants Raj Denhoy – Jefferies...
AxoGen (NASDAQ: AXGN ) : Q2 Non-GAAP EPS of -$0.15; GAAP EPS of -$0.20 beats by $0.21 . More news on: AxoGen, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
ALACHUA, Fla., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the second quarter ended June 30, 2020. Sec...
News, Short Squeeze, Breakout and More Instantly...
ALACHUA and TAMPA, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report second quarter 2024 financial results on Thursday, August 8, 2024, b...
2024-07-01 07:30:05 ET Raymond James analyst issues OUTPERFORM recommendation for AXGN on July 1, 2024 05:51AM ET. AXGN was trading at $7.24 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 recommendations
ALACHUA, Fla. and TAMPA, Fla., July 01, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced making an inducement grant on July 1, 2024, under NASDAQ listing rule 5635(c)(4) in conn...